Symbol |
Name |
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
ATM
|
ATM serine/threonine kinase
|
ATR
|
ATR serine/threonine kinase
|
BCL2
|
B-cell CLL/lymphoma 2
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
BRCA2
|
breast cancer 2, early onset
|
C2ORF40
|
chromosome 2 open reading frame 40
|
CALR
|
calreticulin
|
CDK1
|
cyclin-dependent kinase 1
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
CHEK1
|
checkpoint kinase 1
|
CHEK2
|
checkpoint kinase 2
|
CTC1
|
CTS telomere maintenance complex component 1
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
ENG
|
endoglin
|
ERCC1
|
excision repair cross-complementation group 1
|
HMGA1
|
high mobility group AT-hook 1
|
HMGA2
|
high mobility group AT-hook 2
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
HTT
|
huntingtin
|
ICAM1
|
intercellular adhesion molecule 1
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
ILK
|
integrin-linked kinase
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
MAPK14
|
mitogen-activated protein kinase 14
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
MME
|
membrane metallo-endopeptidase
|
MNT
|
MAX network transcriptional repressor
|
MORC3
|
MORC family CW-type zinc finger 3
|
NOX4
|
NADPH oxidase 4
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
NSMCE2
|
non-SMC element 2, MMS21 homolog (S. cerevisiae)
|
NUP62
|
nucleoporin 62kDa
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
PML
|
promyelocytic leukemia
|
PRELP
|
proline/arginine-rich end leucine-rich repeat protein
|
PRKCD
|
protein kinase C, delta
|
ROMO1
|
reactive oxygen species modulator 1
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
SIRT1
|
sirtuin 1
|
SMC5
|
structural maintenance of chromosomes 5
|
SMC6
|
structural maintenance of chromosomes 6
|
SOD1
|
superoxide dismutase 1, soluble
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
TBX2
|
T-box 2
|
TBX3
|
T-box 3
|
TERF2
|
telomeric repeat binding factor 2
|
TERT
|
telomerase reverse transcriptase
|
TP53
|
tumor protein p53
|
TP63
|
tumor protein p63
|
ULK3
|
unc-51 like kinase 3
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
WRN
|
Werner syndrome, RecQ helicase-like
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|